OBJECTIVE: Elevated glucocorticoid levels are associated with dementia. A glucocorticoid receptor gene variant (ER22/23EK) is related to relative glucocorticoid resistance. We investigated whether the ER22/23EK allele is associated with dementia and structural brain abnormalities. METHODS: This study was performed in two prospective population-based cohort studies among elderly. The first study included 6034 participants who were screened for dementia (mean follow-up 5.8 years). The second study included 1011 elderly subjects with an MRI at baseline and follow-up. The ER22/23EK allele was assessed for association with dementia, cognitive function and white matter lesions. RESULTS: The ER22/23EK allele was associated with a decreased risk of dementia. Among non-demented participants, ER22/23EK-carriers had a better performance on psychomotor speed tests than non-carriers. No differences were found in memory function between genotypes. In addition, both presence and progression of white matter lesions was lower in ER22/23EK-carriers. No association was found with brain atrophy on MRI. CONCLUSIONS: Our findings suggest a protective effect of the ER22/23EK allele on the risk of dementia and white matter lesions.
OBJECTIVE: Elevated glucocorticoid levels are associated with dementia. A glucocorticoid receptor gene variant (ER22/23EK) is related to relative glucocorticoid resistance. We investigated whether the ER22/23EK allele is associated with dementia and structural brain abnormalities. METHODS: This study was performed in two prospective population-based cohort studies among elderly. The first study included 6034 participants who were screened for dementia (mean follow-up 5.8 years). The second study included 1011 elderly subjects with an MRI at baseline and follow-up. The ER22/23EK allele was assessed for association with dementia, cognitive function and white matter lesions. RESULTS: The ER22/23EK allele was associated with a decreased risk of dementia. Among non-demented participants, ER22/23EK-carriers had a better performance on psychomotor speed tests than non-carriers. No differences were found in memory function between genotypes. In addition, both presence and progression of white matter lesions was lower in ER22/23EK-carriers. No association was found with brain atrophy on MRI. CONCLUSIONS: Our findings suggest a protective effect of the ER22/23EK allele on the risk of dementia and white matter lesions.
Authors: Alasdair M J MacLullich; Karen J Ferguson; Louise M Reid; Ian J Deary; John M Starr; Joanna M Wardlaw; Brian R Walker; Ruth Andrew; Jonathan R Seckl Journal: Neurobiol Aging Date: 2010-10-18 Impact factor: 4.673
Authors: Manon J M van Oosten; Radboud J E M Dolhain; Jan W Koper; Elisabeth F C van Rossum; Marieke Emonts; Khik H Han; Jacques M G W Wouters; Johanne M W Hazes; Steven W J Lamberts; Richard A Feelders Journal: Arthritis Res Ther Date: 2010-08-21 Impact factor: 5.156
Authors: Stacey M Leventhal; Debora Lim; Tajia L Green; Anna E Cantrell; Kiho Cho; David G Greenhalgh Journal: BMC Genet Date: 2019-02-08 Impact factor: 2.797
Authors: Steven J A van der Werff; Cornelie D Andela; J Nienke Pannekoek; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee Journal: Neuroimage Clin Date: 2014-02-10 Impact factor: 4.881